Domov › Ploščatocelični karcinom glave in vratu › Ohio › Columbus
Klinične študije za Ploščatocelični karcinom glave in vratu v Columbus, OH
20 študij za Ploščatocelični karcinom glave in vratu išče udeležence na lokacijah v Columbus in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Vključevanje udeležencevFaza 3
- Ohio State University Comprehensive Cancer Center, Columbus
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Vključevanje udeležencevFaza 1
- ALX Center 10, Columbus
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Vključevanje udeležencevFaza 3
- Ohio State University, Columbus
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Vključevanje udeležencevFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- Research Site, Columbus
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Ohio State University, Columbus
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Vključevanje udeležencevOpazovalna študija
- Ohio State University, Columbus
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Vključevanje udeležencevFaza 2
- Ohio State University, Columbus
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Vključevanje udeležencevFaza 2/3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Vključevanje udeležencevFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- The Ohio State University, Columbus
SMP-3124LP in Adults With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Ohio State University, Columbus
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Ohio State University, Columbus
Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer
Vključevanje udeležencevFaza 1
- Ohio State University Comprehensive Cancer Center, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Vključevanje udeležencevFaza 3
- Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
Vključevanje udeležencevFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Vključevanje udeležencev
- Ohio State University Medical Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Vključevanje udeležencevFaza 1/2
- The Ohio State University, Columbus
Študije za Ploščatocelični karcinom glave in vratu v drugih mestih
- Houston, TX47 študij
- Los Angeles, CA42 študij
- Boston, MA40 študij
- New York City, NY39 študij
- Nashville, TN39 študij
- St. Louis, MO28 študij
- Arlington, VA26 študij
- Philadelphia, PA26 študij
- Chicago, IL26 študij
- Atlanta, GA24 študij
- San Antonio, TX22 študij
- New Haven, CT22 študij
Druge študije v Columbus
- Nemalicelični pljučni rak57 študij
- Rak dojke40 študij
- Rak jajčnikov39 študij
- Rak (vse vrste)38 študij
- Rak pljuč37 študij
- Akutna mieločna levkemija35 študij
- Kronična limfocitna levkemija28 študij
- Metastatski rak27 študij
- Rak endometrija25 študij
- Rak prostate24 študij
- Množni mielom24 študij
- Kolorektalni rak24 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.